Walgreens Starts Next-Day Drug Delivery
(Bloomberg) -- Walgreens Boots Alliance Inc. is rolling out a nationwide next-day prescription-delivery service to fend off competition from Amazon.com Inc. and numerous venture capital-backed startups.
Walgreens has thousands of retail stores, which could give it a leg up in speedy distribution of prescription drugs. But Amazon also has a sizable network of stores where consumers can pick up things they order online after its takeover of the grocery chain Whole Foods.
Key Insights
- The new service would allow patients to go online to fill a prescription and pick it up in a drugstore or have it delivered by FedEx Corp. the next day for $4.99. Same-day service will be available in select areas.
- Walgreens and rival CVS Health Corp. face a looming threat from Amazon, which bought online pharmacy PillPack for about $1 billion in June. While Amazon hasn't disclosed its plans, its new online pharmacy has licenses in every state.
- Several venture-backed startups also offer same-day prescription delivery or websites that allow you to pay in advance for drugs and pick them up at a drugstore of your choice.
- CVS started offering one-to-two day home delivery nationwide for $4.99 in June. It also has same day-delivery in certain areas.
Get More
Read the Walgreens news release here.
To contact the reporter on this story: Robert Langreth in New York at rlangreth@bloomberg.net
To contact the editors responsible for this story: Drew Armstrong at darmstrong17@bloomberg.net, Timothy Annett
©2018 Bloomberg L.P.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.
-
You May Inherit The Business. You Must Earn Its Credibility.
Succession tests the founder's ability to share authority as much as it tests the next generation's readiness to assume it.
-
Signing Deals Is One Thing; Making Them Work Is Another | The Week In Whys
Sometimes, things don't turn out as planned. Indian companies have lost some bids to rivals, some projects won't produce until 2030.
-
FOMC Wall, PERM Suspension, Hospital Stocks | Talking Points This Week
A PERM suspension would directly affect green-card sponsorship rather than H-1B visas, so the near-term earnings impact could remain relatively limited. The key question is whether this marks a new phase in US scrutiny of Indian IT.
